bcrm: Bayesian Continual Reassessment Method designs for Phase I dose-finding trials

Sweeting, Michael, Mander, Adrian ORCID: https://orcid.org/0000-0002-0742-9040 and Sabin, Tony 2013. bcrm: Bayesian Continual Reassessment Method designs for Phase I dose-finding trials. Journal of Statistical Software 54 (13) 10.18637/jss.v054.i13

PDF - Published Version Available under License Creative Commons Attribution. Download (448kB)

Abstract

This paper presents the R package bcrm for conducting and assessing Bayesian continual reassessment method (CRM) designs in Phase I dose-escalation trials. CRM designsare a class of adaptive design that select the dose to be given to the next recruited patient based on accumulating toxicity data from patients already recruited into the trial, often using Bayesian methodology. Despite the original CRM design being proposed in 1990, the methodology is still not widely implemented within oncology Phase I trials. The aim of this paper is to demonstrate, through example of the bcrm package, how a variety of possible designs can be easily implemented within the R statistical software, and how properties of the designs can be communicated to trial investigators using simple textual and graphical output obtained from the package. This in turn should facilitate an iterative process to allow a design to be chosen that is suitable to the needs of the investigator. Our bcrm package is the first to offer a large comprehensive choice of CRM designs, priors and escalation procedures, which can be easily compared and contrasted within the package through the assessment of operating characteristics.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	University of California, Los Angeles
ISSN:	1548-7660
Date of First Compliant Deposit:	9 October 2019
Last Modified:	04 May 2023 08:24
URI:	https://orca.cardiff.ac.uk/id/eprint/123287

Citation Data

Cited 27 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item